An optimized expression vector for improving the yield of dengue virus-like particles from transfected insect cells
- PMID: 24814967
- DOI: 10.1016/j.jviromet.2014.04.019
An optimized expression vector for improving the yield of dengue virus-like particles from transfected insect cells
Abstract
Recombinant virus-like particles (rVLPs) of flaviviruses are non-infectious particles released from cells expressing the envelope glycoproteins prM and E. Dengue virus rVLPs are recognized as a potential vaccine candidate, but large scale production of these particles is hindered by low yields and the occurrence of cytopathic effects. In an approach to improve the yield of rVLPs from transfected insect cells, several components of a dengue serotype 2 virus prM+E expression cassette were modified and the effect of these modifications was assessed during transient expression. Enhancement of extracellular rVLP levels by simultaneous substitutions of the prM signal peptide and the stem-anchor region of E with homologous cellular and viral counterparts, respectively, was further augmented by codon optimization. Extensive formation of multinucleated cells following transfection with the codon-optimized expression cassette was abrogated by introducing an E fusion loop mutation. This mutation also helped restore the extracellular E levels affected negatively by alteration of a charged residue at the pr-M junction, which was intended to promote maturation of rVLPs during export. Optimized expression cassettes generated in this multiple add-on modification approach should be useful in the generation of stably expressing clones and production of dengue virus rVLPs for immunogenicity studies.
Keywords: Dengue virus; Insect cell lines; Transfection; Vaccine candidate; Virus-like particle.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.J Virol. 2017 Nov 14;91(23):e01181-17. doi: 10.1128/JVI.01181-17. Print 2017 Dec 1. J Virol. 2017. PMID: 28956764 Free PMC article.
-
Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.Vaccine. 2013 Oct 17;31(44):5134-40. doi: 10.1016/j.vaccine.2013.08.027. Epub 2013 Aug 22. Vaccine. 2013. PMID: 23973247
-
Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.BMC Microbiol. 2014 Dec 18;14:233. doi: 10.1186/s12866-014-0233-3. BMC Microbiol. 2014. PMID: 25520151 Free PMC article.
-
Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells.Vaccine. 2015 Oct 13;33(42):5613-5622. doi: 10.1016/j.vaccine.2015.08.090. Epub 2015 Sep 14. Vaccine. 2015. PMID: 26382602
-
A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone.Expert Rev Vaccines. 2016;15(4):497-508. doi: 10.1586/14760584.2016.1128328. Epub 2016 Feb 22. Expert Rev Vaccines. 2016. PMID: 26635182 Review.
Cited by
-
Formation of Virus-Like Particles of the Dengue Virus Serotype 2 Expressed in Silkworm Larvae.Mol Biotechnol. 2019 Nov;61(11):852-859. doi: 10.1007/s12033-019-00210-5. Mol Biotechnol. 2019. PMID: 31473916
-
Heterologous prime-boost immunization induces protection against dengue virus infection in cynomolgus macaques.J Virol. 2023 Nov 30;97(11):e0096323. doi: 10.1128/jvi.00963-23. Epub 2023 Oct 17. J Virol. 2023. PMID: 37846984 Free PMC article.
-
Production of Envelope Protein-Based Virus-like Particles of DENV‑2 in and Investigation of Their Binding Interactions with Gallic Acid Derivatives of Glucose as Potential Drug Candidates.ACS Omega. 2025 Jul 21;10(30):33090-33107. doi: 10.1021/acsomega.5c02548. eCollection 2025 Aug 5. ACS Omega. 2025. PMID: 40787407 Free PMC article.
-
Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay.J Immunol Methods. 2021 Jan;488:112900. doi: 10.1016/j.jim.2020.112900. Epub 2020 Oct 16. J Immunol Methods. 2021. PMID: 33075363 Free PMC article.
-
Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines.Vaccines (Basel). 2020 Aug 27;8(3):481. doi: 10.3390/vaccines8030481. Vaccines (Basel). 2020. PMID: 32867194 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials